Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2025-12-25 @ 2:16 PM
NCT ID: NCT03638466
Description: Adverse events reporting pertains to the Safety Population which included all subjects randomized and who received at least 1 dose of study drug.
Frequency Threshold: 5
Time Frame: Visit 3 (Day 1) to Visit 6 (Week5)-End of Study, a total of 5 weeks
Study: NCT03638466
Study Brief: Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Subjects treated with Placebo 0 None 0 4 2 4 View
High Dose SPN-810 Subjects treated with 36 mg SPN-810 0 None 0 3 1 3 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (18.1) View
Decrease appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (18.1) View
Blood Prolactin Increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (18.1) View